EMILY RAMIREZ: Open Payments
NPI 1447918628 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $138 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 4 | $176 |
| GENZYME CORPORATION | 1 | $106 |
| IntraBio Inc | 1 | $39 |
| Celltrion USA Inc. | 1 | $30 |
| PTC Therapeutics, Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Palynziq, CERDELGA, AQNEURSA, VEGZELMA, ELFABRIO, ELAPRASE.
Industry payments across CA — which companies pay providers there.
